D. Pectasides

1.9k total citations
55 papers, 1.3k citations indexed

About

D. Pectasides is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, D. Pectasides has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in D. Pectasides's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Treatment and Pharmacology (11 papers) and Colorectal Cancer Treatments and Studies (7 papers). D. Pectasides is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Treatment and Pharmacology (11 papers) and Colorectal Cancer Treatments and Studies (7 papers). D. Pectasides collaborates with scholars based in Greece, United States and United Kingdom. D. Pectasides's co-authors include Eirini Pectasides, A. Psyrri, Melina Pectasides, Kyriaki Pliarchopoulou, T. Economopoulos, George Fountzilas, Gerasimos Aravantinos, B Dhokia, Mark Larché and Nigel Courtenay-Luck and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

D. Pectasides

54 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Pectasides Greece 21 590 361 299 293 225 55 1.3k
Scott R. Gerst United States 21 344 0.6× 629 1.7× 258 0.9× 469 1.6× 158 0.7× 47 1.4k
Thèrése Bocklage United States 23 418 0.7× 221 0.6× 497 1.7× 396 1.4× 120 0.5× 73 1.5k
Shigeo Aizawa Japan 16 407 0.7× 321 0.9× 406 1.4× 420 1.4× 142 0.6× 56 1.3k
Wei Deng China 22 401 0.7× 296 0.8× 339 1.1× 414 1.4× 81 0.4× 93 1.4k
Katsushige Yamashiro Japan 22 423 0.7× 182 0.5× 171 0.6× 606 2.1× 223 1.0× 78 1.4k
Maritza Martel United States 19 381 0.6× 363 1.0× 308 1.0× 255 0.9× 176 0.8× 32 1.5k
Gerhard Gebauer Germany 23 854 1.4× 205 0.6× 237 0.8× 227 0.8× 202 0.9× 49 1.4k
Eirini Pectasides Greece 24 621 1.1× 493 1.4× 617 2.1× 388 1.3× 600 2.7× 49 1.8k
Fritz Lin United States 23 530 0.9× 657 1.8× 511 1.7× 517 1.8× 139 0.6× 51 1.9k
Gordon H. Yu United States 19 500 0.8× 575 1.6× 217 0.7× 384 1.3× 84 0.4× 76 1.6k

Countries citing papers authored by D. Pectasides

Since Specialization
Citations

This map shows the geographic impact of D. Pectasides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Pectasides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Pectasides more than expected).

Fields of papers citing papers by D. Pectasides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Pectasides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Pectasides. The network helps show where D. Pectasides may publish in the future.

Co-authorship network of co-authors of D. Pectasides

This figure shows the co-authorship network connecting the top 25 collaborators of D. Pectasides. A scholar is included among the top collaborators of D. Pectasides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Pectasides. D. Pectasides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pectasides, D., et al.. (2008). Primary Ovarian Lymphoma: Report of Two Cases and Review of the Literature. Journal of Chemotherapy. 20(4). 513–517. 2 indexed citations
2.
Pectasides, D., et al.. (2008). Current management of stage I testicular non-seminomatous germ cell tumours. Critical Reviews in Oncology/Hematology. 70(2). 114–123. 8 indexed citations
3.
Pectasides, D., Amanda Psyrri, Melina Pectasides, & Theofanis Economopoulos. (2006). Optimal therapy for platinum-resistant recurrent ovarian cancer: doxorubicin, gemcitabine or topotecan?. Expert Opinion on Pharmacotherapy. 7(8). 975–987. 12 indexed citations
4.
Pectasides, D., Melina Pectasides, & T. Economopoulos. (2006). Merkel cell cancer of the skin. Annals of Oncology. 17(10). 1489–1495. 81 indexed citations
5.
Nikolaou, Maria, et al.. (2006). Intramedullary Spinal Cord Metastases from Atypical Small Cell Lung Cancer: A Case Report and Literature Review. Cancer Investigation. 24(1). 46–49. 7 indexed citations
6.
Economopoulos, T., Sotirios G. Papageorgiou, Meletios Α. Dimopoulos, et al.. (2005). Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid Neoplasms. Acta Haematologica. 113(2). 97–103. 26 indexed citations
7.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2005). Comparison of docetaxel and docetaxel–irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial. Annals of Oncology. 16(2). 294–299. 71 indexed citations
8.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2004). Gemcitabine and oxaliplatin (GEMOX) in patients withcisplatin-refractory germ cell tumors: a phase II study. Annals of Oncology. 15(3). 493–497. 75 indexed citations
9.
Pectasides, D., Melina Pectasides, Dimitrios Farmakis, et al.. (2003). Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Annals of Oncology. 14(4). 537–542. 26 indexed citations
10.
11.
Pectasides, D., et al.. (2002). Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial. Annals of Oncology. 13(2). 243–250. 39 indexed citations
12.
Pectasides, D., Haralabos P. Kalofonos, Epaminontas Samantas, et al.. (2001). An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.. PubMed. 21(4B). 3005–10. 17 indexed citations
13.
Samantas, Epaminontas, Dimosthenis Skarlos, D. Pectasides, et al.. (1999). Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer. Lung Cancer. 23(2). 159–168. 12 indexed citations
14.
Pectasides, D., Gerasimos Aravantinos, A. Visvikis, et al.. (1999). Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience. Oncology. 57(1). 1–9. 9 indexed citations
15.
Pectasides, D., et al.. (1998). Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer. Oncology. 55(3). 228–234. 8 indexed citations
16.
17.
Nicolaides, C., George Fountzilas, Nicholas Zoumbos, et al.. (1998). Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index. Oncology. 55(5). 405–415. 31 indexed citations
18.
Fountzilas, George, A. Athanassiades, T. Giannakakis, et al.. (1997). A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study. Annals of Oncology. 8(12). 1213–1220. 28 indexed citations
19.
Pectasides, D., et al.. (1992). Cerebrovascular Accidents Following Hormonochemotherapy in Cancer Patients. American Journal of Clinical Oncology. 15(2). 168–173. 2 indexed citations
20.
Pectasides, D., et al.. (1991). Correlation of Abdominal Computed Tomography Scanning and Second-Look Operation Findings in Ovarian Cancer Patients. American Journal of Clinical Oncology. 14(6). 457–462. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Scott R. Gerst Breakdown of academic impact, for papers by Thèrése Bocklage Breakdown of academic impact, for papers by Shigeo Aizawa Breakdown of academic impact, for papers by Wei Deng Breakdown of academic impact, for papers by Katsushige Yamashiro Breakdown of academic impact, for papers by Maritza Martel Breakdown of academic impact, for papers by Gerhard Gebauer Breakdown of academic impact, for papers by Eirini Pectasides Breakdown of academic impact, for papers by Fritz Lin Breakdown of academic impact, for papers by Gordon H. Yu
Rankless by CCL
2026